Free Trial

iSpecimen (ISPC) Competitors

iSpecimen logo
$1.14 -0.03 (-2.55%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ISPC vs. KRKR, GLXG, SUGP, VCIG, DRCT, VS, AWX, CLIK, INTJ, and SRAX

Should you be buying iSpecimen stock or one of its competitors? The main competitors of iSpecimen include 36Kr (KRKR), Galaxy Payroll Group (GLXG), SU Group (SUGP), VCI Global (VCIG), Direct Digital (DRCT), Versus Systems (VS), Avalon (AWX), Click (CLIK), Intelligent Group (INTJ), and SRAX (SRAX). These companies are all part of the "business services" industry.

iSpecimen vs.

iSpecimen (NASDAQ:ISPC) and 36Kr (NASDAQ:KRKR) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, community ranking, media sentiment and earnings.

36Kr received 16 more outperform votes than iSpecimen when rated by MarketBeat users. However, 75.00% of users gave iSpecimen an outperform vote while only 54.29% of users gave 36Kr an outperform vote.

CompanyUnderperformOutperform
iSpecimenOutperform Votes
3
75.00%
Underperform Votes
1
25.00%
36KrOutperform Votes
19
54.29%
Underperform Votes
16
45.71%

In the previous week, iSpecimen had 1 more articles in the media than 36Kr. MarketBeat recorded 1 mentions for iSpecimen and 0 mentions for 36Kr. 36Kr's average media sentiment score of 0.00 beat iSpecimen's score of -0.95 indicating that 36Kr is being referred to more favorably in the news media.

Company Overall Sentiment
iSpecimen Negative
36Kr Neutral

iSpecimen has a beta of 1.73, suggesting that its stock price is 73% more volatile than the S&P 500. Comparatively, 36Kr has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500.

iSpecimen has higher earnings, but lower revenue than 36Kr. 36Kr is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iSpecimen$9.29M0.31-$11.10M-$12.89-0.09
36Kr$231.07M0.05-$12.71M-$6.00-0.98

36Kr has a net margin of 0.00% compared to iSpecimen's net margin of -91.66%. 36Kr's return on equity of 0.00% beat iSpecimen's return on equity.

Company Net Margins Return on Equity Return on Assets
iSpecimen-91.66% -139.25% -73.97%
36Kr N/A N/A N/A

13.6% of iSpecimen shares are owned by institutional investors. Comparatively, 0.1% of 36Kr shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by insiders. Comparatively, 39.4% of 36Kr shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

36Kr beats iSpecimen on 8 of the 15 factors compared between the two stocks.

Get iSpecimen News Delivered to You Automatically

Sign up to receive the latest news and ratings for ISPC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ISPC vs. The Competition

MetriciSpecimenCommercial physical research IndustryMedical SectorNASDAQ Exchange
Market Cap$2.87M$3.01B$5.36B$8.39B
Dividend YieldN/A2.27%5.22%4.10%
P/E Ratio-0.06109.8926.5919.72
Price / Sales0.31162.00391.61116.20
Price / CashN/A34.5738.2534.62
Price / Book0.052.346.794.51
Net Income-$11.10M$118.81M$3.23B$248.18M
7 Day Performance-2.30%-2.40%4.03%1.14%
1 Month Performance-2.71%-1.73%12.22%15.07%
1 Year Performance367.14%-12.09%16.76%6.59%

iSpecimen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ISPC
iSpecimen
0.2943 of 5 stars
$1.15
-2.3%
N/A+373.0%$2.87M$9.29M-0.0660Earnings Report
KRKR
36Kr
N/A$5.80
+2.8%
N/A-39.1%$11.43M$231.07M-0.97570
GLXG
Galaxy Payroll Group
N/A$0.64
+9.5%
N/AN/A$11.32M$30.12M0.0026Gap Down
SUGP
SU Group
N/A$0.80
+4.0%
N/A-63.0%$11.08M$182.16M0.00N/AGap Down
VCIG
VCI Global
0.3344 of 5 stars
$5.02
-13.6%
N/A-99.6%$10.55M$111.09M0.00102Positive News
Gap Up
DRCT
Direct Digital
1.9287 of 5 stars
$0.59
-8.3%
$6.00
+912.8%
-86.7%$10.53M$48.17M-0.5160Gap Down
VS
Versus Systems
0.9628 of 5 stars
$2.02
+2.0%
$2.00
-1.0%
+39.7%$9.90M$57,288.00-1.318Earnings Report
Gap Up
AWX
Avalon
N/A$2.38
-1.6%
N/A+3.0%$9.28M$83.80M9.52610News Coverage
Analyst Forecast
CLIK
Click
N/A$0.26
+4.4%
N/AN/A$8.27M$6.05M0.00N/ATrending News
Gap Down
High Trading Volume
INTJ
Intelligent Group
N/A$0.63
+8.3%
N/A-48.6%$8.24M$20.29M0.0017Positive News
High Trading Volume
SRAX
SRAX
N/A$0.25
-34.2%
N/A+66.7%$7.29M$29.29M0.00130Gap Down

Related Companies and Tools


This page (NASDAQ:ISPC) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners